HC Wainwright & Co. Maintains Buy on MiMedx Group, Raises Price Target to $11
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains a 'Buy' rating on MiMedx Group (NASDAQ:MDXG) and raises the price target from $8 to $11.
August 04, 2023 | 10:47 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
MiMedx Group's price target has been raised from $8 to $11 by HC Wainwright & Co., maintaining a 'Buy' rating.
The raised price target and maintained 'Buy' rating by HC Wainwright & Co. indicates a positive outlook for MiMedx Group. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100